Cargando…
Safety of low dose efavirenz regimen in Indian adults with HIV-1 infection: Insights from a phase 4 interventional randomised trial
BACKGROUND: A randomized interventional phase 4 study in the Indian population confirmed the non-inferiority of the combination tenofovir/lamivudine/efavirenz (TLE)-400 to TLE600. The current manuscript describes in detail the safety profile and patient-reported safety outcomes obtained from the pha...
Autores principales: | Dravid, Ameet N., Pilawan, Anant S., Anuradha, S., Morkar, Dnyanesh N., Ramapuram, John T., Madhukarrao, Kulkarni Milind, Naik, K. Sunil, Bhrusundi, Milind, Raveendra, K.R., Nageswaramma, Siddabathuni, Kulkarni, Vinay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627601/ https://www.ncbi.nlm.nih.gov/pubmed/37933062 http://dx.doi.org/10.1097/MD.0000000000035643 |
Ejemplares similares
-
Efficacy and safety of 400 mg efavirenz versus standard 600 mg dose when taken with tenofovir and lamivudine combination in Indian adult patients with HIV-1 infection: An open-label, interventional, randomized, non-inferiority trial
por: Dravid, Ameet, et al.
Publicado: (2022) -
A Phase IV Study on Safety, Tolerability and Efficacy of Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate in Treatment Naïve Adult Indian Patients Living with HIV-1
por: Dravid, Ameet, et al.
Publicado: (2022) -
Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India
por: Dravid, Ameet N., et al.
Publicado: (2018) -
Two treatment strategies for management of Neurosymptomatic cerebrospinal fluid HIV escape in Pune, India
por: Dravid, Ameet N., et al.
Publicado: (2020) -
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals
por: Cain, Lauren E., et al.
Publicado: (2016)